Tourmaline Bio (TRML) Misses Q4 EPS by 86c
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Join SI Premium – FREE
Tourmaline Bio (NASDAQ: TRML) reported Q4 EPS of ($0.86).
For earnings history and earnings-related data on Tourmaline Bio (TRML) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sanuwave Q2 2026 revenue tops revised guidance range
- Goldman Sachs Downgrades EssilorLuxottica SA (EL:FP) (ESLOY) to Neutral
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
